|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/24/20 Orthofix Medical Inc. 10-K 12/31/19 125:21M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 2.09M
2: EX-4.2 Instrument Defining the Rights of Security Holders HTML 49K
3: EX-10.11 Material Contract HTML 89K
4: EX-10.12 Material Contract HTML 61K
5: EX-10.13 Material Contract HTML 61K
6: EX-10.37 Material Contract HTML 53K
7: EX-10.38 Material Contract HTML 158K
8: EX-21.1 Subsidiaries List HTML 40K
9: EX-23.1 Consent of Experts or Counsel HTML 40K
10: EX-31.1 Certification -- §302 - SOA'02 HTML 43K
11: EX-31.2 Certification -- §302 - SOA'02 HTML 44K
12: EX-32.1 Certification -- §906 - SOA'02 HTML 39K
21: R1 Document and Entity Information HTML 98K
85: R2 Consolidated Balance Sheets HTML 120K
98: R3 Consolidated Balance Sheets (Parenthetical) HTML 47K
64: R4 Consolidated Statements of Operations and HTML 162K
Comprehensive Income (Loss)
22: R5 Consolidated Statements of Changes in HTML 77K
Shareholders' Equity
87: R6 Consolidated Statements of Cash Flows HTML 141K
100: R7 Business and basis of consolidation HTML 40K
62: R8 Significant accounting policies HTML 77K
24: R9 Recently adopted accounting standards and recently HTML 69K
issued accounting pronouncements
84: R10 Acquisitions HTML 216K
102: R11 Inventories HTML 61K
63: R12 Property, plant and equipment HTML 92K
25: R13 Intangible assets HTML 126K
83: R14 Goodwill HTML 59K
101: R15 Leases HTML 307K
61: R16 Other current liabilities HTML 73K
23: R17 Long-term debt HTML 48K
86: R18 Fair value measurements and investments HTML 268K
99: R19 Commitments and Contingencies HTML 49K
55: R20 Shareholder's equity HTML 103K
41: R21 Revenue recognition and accounts receivable HTML 82K
82: R22 Business segment information HTML 324K
125: R23 Acquisition-Related Amortization and Remeasurement HTML 59K
54: R24 Share-based compensation HTML 269K
40: R25 Defined Contribution Plans and deferred HTML 42K
compensation
81: R26 Income taxes HTML 351K
124: R27 Earnings per share (Eps) HTML 76K
53: R28 Quarterly financial data (Unaudited) HTML 263K
42: R29 Subsequent Events HTML 38K
19: R30 Significant accounting policies (Policies) HTML 96K
57: R31 Acquisitions (Tables) HTML 216K
103: R32 Inventories (Tables) HTML 61K
88: R33 Property, plant and equipment (Tables) HTML 88K
20: R34 Intangible assets (Tables) HTML 125K
59: R35 Goodwill (Tables) HTML 57K
104: R36 Leases (Tables) HTML 310K
89: R37 Other current liabilities (Tables) HTML 71K
18: R38 Fair value measurements and investments (Tables) HTML 257K
60: R39 Shareholders' equity (Tables) HTML 100K
38: R40 Revenue recognition and accounts receivable HTML 58K
(Tables)
48: R41 Business segment information (Tables) HTML 325K
114: R42 Acquisition-Related Amortization and Remeasurement HTML 58K
(Tables)
72: R43 Share-based compensation (Tables) HTML 246K
39: R44 Income taxes (Tables) HTML 347K
50: R45 Earnings per share (Eps) (Tables) HTML 72K
115: R46 Quarterly financial data (Unaudited) (Tables) HTML 262K
73: R47 Business and Basis of Consolidation - Additional HTML 42K
Information (Detail)
37: R48 Significant Accounting Policies - Additional HTML 72K
Information (Detail)
52: R49 Recently Adopted Accounting Standards and Recently HTML 48K
Issued Accounting Pronouncements - Additional
Information (Detail)
71: R50 Acquisitions - Additional Information (Detail) HTML 83K
31: R51 Acquisitions - Schedule of Fair Value of HTML 43K
Consideration Transferred (Detail)
91: R52 Acquisitions - Summary of Fair Values of Assets HTML 141K
Acquired and Liabilities Assumed (Detail)
106: R53 Inventories - Schedule of Inventories (Detail) HTML 48K
70: R54 Property, Plant and Equipment - Schedule of Useful HTML 53K
Lives of the Assets (Detail)
30: R55 Property, Plant and Equipment - Additional HTML 49K
Information (Detail)
90: R56 Property, Plant and Equipment - Schedule of HTML 60K
Property, Plant and Equipment (Detail)
105: R57 Intangible Assets - Schedule of Intangible Assets HTML 64K
(Detail)
69: R58 Intangible Assets - Additional Information HTML 46K
(Detail)
32: R59 Intangible Assets - Schedule of Future HTML 52K
Amortization Expense (Detail)
76: R60 Goodwill - Schedule of Net Carrying Amount of HTML 43K
Goodwill (Detail)
120: R61 Leases - Additional Information (Detail) HTML 42K
46: R62 Leases - Summary of Net Impact of Adoption Balance HTML 127K
Sheet (Detail)
35: R63 Leases - Summary of Lease Portfolio (Detail) HTML 78K
75: R64 Leases - Summary of Components of Lease Costs HTML 50K
(Detail)
119: R65 Leases - Summary of Supplemental Cash Flow HTML 49K
Information Related to Leases (Detail)
45: R66 Leases - Summary of Remaining Lease Liabilities HTML 85K
(Detail)
34: R67 Other Current Liabilities - Summary of Other HTML 56K
Current Liabilities (Detail)
78: R68 Other Current Liabilities - Additional Information HTML 38K
(Detail)
116: R69 Long-Term Debt - Additional Information (Detail) HTML 102K
108: R70 Fair Value Measurements and Investments- Schedule HTML 70K
of Financial Assets and Liabilities Recorded at
Fair Value on Recurring Basis (Detail)
95: R71 Fair Value Measurements and Investments - HTML 122K
Additional Information (Detail)
27: R72 Fair Value Measurements and Investments - Schedule HTML 48K
of Change in Valuation of Securities (Detail)
66: R73 Fair Value Measurements and Investments - Schedule HTML 54K
of Reconciliation of Debt Securities (Detail)
109: R74 Fair Value Measurements and Investments - Schedule HTML 47K
of Reconciliation For Contingent Consideration
Measured At Fair Value Using Significant
Unobservable Inputs (Level 3) (Detail)
96: R75 Commitments and Contingencies - Additional HTML 56K
Information (Detail)
28: R76 Shareholders' Equity - Components of Changes in HTML 73K
Accumulated Other Comprehensive Income (Loss)
(Detail)
67: R77 Revenue Recognition and Accounts Receivable - HTML 44K
Schedule of Net Sales (Detail)
112: R78 Revenue Recognition and Accounts Receivable - HTML 82K
Additional Information (Detail)
93: R79 Business Segment Information - Additional HTML 36K
Information (Detail)
107: R80 Business Segment Information - Schedule of Net HTML 62K
Sales by Major Product Category by Reporting
Segment (Detail)
94: R81 Business Segment Information - Summary of EBIDTA HTML 55K
by Reporting Segment (Detail)
26: R82 Business Segment Information - Schedule of HTML 46K
Depreciation and Amortization by Reporting Segment
(Detail)
65: R83 Business Segment Information - Summary of Net HTML 59K
Sales by Geographic Destination (Detail)
110: R84 Business Segment Information - Summary of Net HTML 61K
Sales by Geographic Destination for Each Reporting
Unit (Detail)
97: R85 Business Segment Information - Summary of HTML 52K
Property, Plant and Equipment of Reporting
Segments by Geographic Area (Detail)
29: R86 Acquisition-Related Amortization and Remeasurement HTML 42K
- Components of Acquisition-Related Amortization
and Remeasurement (Detail)
68: R87 Share-based Compensation - Additional Information HTML 212K
(Detail)
111: R88 Share-based Compensation - Schedule of Share-Based HTML 61K
Compensation by Line Item in Consolidated
Statements of Income (Detail)
92: R89 Share-based Compensation - Schedule of Assumptions HTML 56K
Used in Determining Fair Value of Stock Options
Granted (Detail)
77: R90 Share-based Compensation - Schedule of Stock HTML 76K
Option Plans (Detail)
121: R91 Share-based Compensation - Schedule of Changes in HTML 70K
Time-Based, Performance-Based and Market-Based
Restricted Stock Awards and Stock Units (Detail)
47: R92 Defined Contribution Plans and Deferred HTML 65K
Compensation - Additional Information (Detail)
36: R93 Income Taxes - Schedule of Income (Loss) from HTML 43K
Continuing Operations Before Provision for Income
Taxes (Detail)
74: R94 Income Taxes - Schedule of Provision for Income HTML 58K
Taxes on Continuing Operations (Detail)
118: R95 Income Taxes - Schedule of Effective Income Tax HTML 124K
Rate Reconciliation for Continuing Operations
(Detail)
44: R96 Income Taxes - Additional Information (Detail) HTML 98K
33: R97 Income Taxes - Schedule of Deferred Tax Assets and HTML 75K
Liabilities (Detail)
79: R98 Income Taxes - Schedule of Gross Unrecognized Tax HTML 47K
Benefits (Excluding Interest and Penalties)
(Detail)
117: R99 Earnings Per Share (EPS) - Schedule of HTML 52K
Reconciliation of Weighted Average Shares Used in
the Diluted EPS (Detail)
56: R100 Earnings Per Share (EPS) - Additional Information HTML 41K
(Detail)
43: R101 Quarterly Financial Data - Condensed Consolidated HTML 88K
Statement of Operations (Detail)
80: R102 Quarterly Financial Data - Condensed Consolidated HTML 41K
Statement of Operations (Parenthetical) (Detail)
122: R103 Subsequent Events - Additional Information HTML 42K
(Detail)
123: XML IDEA XML File -- Filing Summary XML 231K
58: XML XBRL Instance -- ofix-10k_20191231_htm XML 6.15M
113: EXCEL IDEA Workbook of Financial Reports XLSX 142K
14: EX-101.CAL XBRL Calculations -- ofix-20191231_cal XML 357K
15: EX-101.DEF XBRL Definitions -- ofix-20191231_def XML 985K
16: EX-101.LAB XBRL Labels -- ofix-20191231_lab XML 2.09M
17: EX-101.PRE XBRL Presentations -- ofix-20191231_pre XML 1.69M
13: EX-101.SCH XBRL Schema -- ofix-20191231 XSD 308K
51: JSON XBRL Instance as JSON Data -- MetaLinks 531± 892K
49: ZIP XBRL Zipped Folder -- 0001564590-20-006037-xbrl Zip 504K
Exhibit 10.12
Stock Unit Grant Agreement
under the Orthofix Medical Inc.
Amended and Restated 2012 Long-Term Incentive Plan
This Stock Unit Grant Agreement (the “Agreement”) is made this 1st day of April, 2019 (the “Grant Date”) between Orthofix Medical Inc., a Delaware corporation (the “Company”), and the person signing this Agreement adjacent to the caption “Award Recipient” on the signature page hereof (the “Award Recipient”). Capitalized terms used and not otherwise defined herein shall have the meanings attributed thereto in the Amended and Restated Orthofix Medical Inc. 2012 Long-Term Incentive Plan (the “Plan”).
WHEREAS, pursuant to the Plan, the Company desires to afford the Award Recipient the opportunity to acquire shares of Stock on the terms and conditions set forth herein;
NOW, THEREFORE, in connection with the mutual covenants hereinafter set forth and for other good and valuable consideration, the parties hereto agree as follows:
1.Grant of Stock Units.
(a)Number of Shares/Vesting. The Company hereby grants to the Award Recipient, on the Grant Date, Stock Units under the Plan relating to 35,587 shares of Stock, subject to the vesting schedule and terms and conditions set forth below (the “Award”). Subject to earlier termination in accordance with the Plan or this Agreement and the terms and conditions herein, Stock Units granted under this Agreement shall vest with respect to all of the shares of Stock covered hereby on the first anniversary of the Grant Date (the “Vesting Date”) provided that Award Recipient (i) has remained employed by the Company through the Target Retirement Date (as defined in the Transition and Retirement Agreement) or otherwise has had his employment with the Company terminated by the Company without Cause (as defined in the Change in Control and Severance Agreement) prior to the Target Retirement Date and (ii) has complied with the terms of the Consulting Agreement (as defined in the Transition and Retirement Agreement) through the Vesting Date; provided further, however, for the avoidance of doubt, that there shall be no proportionate or partial vesting in the period prior to the Vesting Date.
(b)Additional Documents. The Award Recipient agrees to execute such additional documents and complete and execute such forms as the Company may require for purposes of this Agreement.
(c)Issuance of Stock. The shares of Stock underlying the Award Recipient’s vested Stock Units will be issued no later than 30 days following the Vesting Date (the date or dates such shares of Stock are delivered, the “Settlement Date”). The issuance of shares of Stock under this grant shall be evidenced in such a manner as the Company, in its discretion, will deem appropriate, including, without limitation, book-entry registration or issuance of one or more stock certificates. On the Settlement Date, the Company shall also deliver to the Award Recipient the number of additional shares of Stock, the number of any other securities of the Company and the amount of any other property (in the case of cash dividends, assuming such dividends had been reinvested in shares of Stock as of the ex-dividend date thereof), in each case that the Company distributed per share of Stock to holders generally during the period commencing on the Grant Date and ending on the applicable Settlement Date, multiplied by the number of shares of Stock that are being delivered to the Award Recipient under this paragraph, without interest, and less any tax withholding amount applicable to such distribution. To the extent that the Stock Units are forfeited prior to vesting, the right to receive such distributions shall also be forfeited.
(d)Shareholder Rights. The Award Recipient has no rights as a shareholder with respect to the shares of Stock underlying the Stock Units unless and until the Stock relating to the Stock Units has been delivered. No adjustments are made for dividends, distributions, or other rights if the applicable record date occurs before the certificate is issued (or appropriate book entry is made), except as described above.
2.Incorporation of Plan. The Award Recipient acknowledges receipt of the Plan, a copy of which is annexed hereto, and represents that he is familiar with its terms and provisions and hereby accepts this grant of Stock Units subject to all of the terms and provisions of the Plan and all interpretations, amendments, rules and regulations which may, from time to time, be promulgated and adopted pursuant to the Plan. The Plan is incorporated herein by reference. In the event of any conflict or inconsistency between the Plan and this Agreement,
Exhibit 10.12
the Plan shall govern and this Agreement shall be interpreted to minimize or eliminate any such conflict or inconsistency.
3.Restrictions on Transfer. To the extent not yet vested, the Stock Units may not be sold, transferred, assigned, transferred, pledged, hypothecated, or otherwise encumbered or disposed of, whether by operation of law or otherwise, nor may the Stock Units be made subject to execution, attachment, or similar process. If the Award Recipient attempts to do any of these things, he will immediately and automatically forfeit the Stock Units.
4.Termination of Service; Change in Control.
(a)Certain Terminations of Service. If the Award Recipient fails to satisfy the condition set forth in Section 1(a)(i) or the condition set forth in Section 1(a)(ii), in each case other than as a result of the Award Recipient’s death or Disability prior to the Vesting Date, all of the Stock Units shall be forfeited by the Award Recipient and cancelled by the Company as of the date that such satisfaction failure occurs, and the Award Recipient shall have no further right or interest therein unless the Committee in its sole discretion shall determine otherwise.
(b)Termination of Service for Death or Disability. If the Award Recipient fails to satisfy the condition set forth in Section 1(a)(i) and/or the condition set forth in Section 1(a)(ii), in each case solely as a result of the Award Recipient’s death or Disability prior to the Vesting Date, the Stock Units shall automatically vest in full as of the date of the Award Recipient’s termination of Service and shall be delivered within 30 days of such termination of Service.
The Company shall have the right to require the Award Recipient to remit to the Company any and all amounts sufficient to satisfy any withholding or other taxes that may be due as a result of the issuance of shares of Stock subject to the Stock Units. At the time of the Settlement Date (or, in the event that tax withholding is required as of an earlier date, then such earlier date), the Award Recipient shall pay in cash to the Company any amount that the Company may reasonably determine to be necessary to satisfy such withholding or other tax obligation. The Company shall have the right, but not the obligation, to permit or require the Award Recipient to satisfy, in whole or in part, such obligation to remit withholding or other taxes, (a) by directing the Company to withhold shares of Stock that would otherwise become vested, or (b) by entering into a “same day sale” commitment with a broker-dealer that is a member of the Financial Industry Regulatory Authority (a “FINRA Dealer”) whereby Award Recipient irrevocably elects to sell a portion of the shares of Stock to be delivered in connection with the Stock Units to satisfy withholding obligations and whereby the FINRA Dealer irrevocably commits to forward the proceeds necessary to satisfy the withholding obligations directly to the Company or any Affiliate in each case pursuant to such rules as the Committee may establish from time to time. The Company, in its sole discretion, may also permit, the Award Recipient to satisfy, in whole or in part, such obligation to remit withholding or other taxes, by delivering to the Company shares of Stock already owned by the Award Recipient and not then subject to any repurchase, forfeiture, unfulfilled vesting, or similar requirements. The Company shall also have the right to deduct from all cash payments made pursuant to, or in connection with, the Stock Units, the federal, state, or local taxes required to be withheld with respect to such payments. The maximum number of shares of Stock that may be withheld to satisfy any federal, state, or local tax requirements may not exceed such number of shares of Stock having a Fair Market Value equal to the minimum statutory amount required by the Company to be withheld and paid to any such federal, state, or local taxing authority with respect to such vesting or payment; provided, however, for so long as Accounting Standards Update 2016-09 or a similar rule remains in effect, the Committee has full discretion to choose, or to allow the Award Recipient to elect, to withhold a number of shares of Stock having an aggregate Fair Market Value that is greater than the applicable minimum required statutory withholding obligation (but such withholding may in no event be in excess of the maximum required statutory withholding obligation in such Award Recipient’s relevant tax jurisdiction).
6.No Employment or Other Rights. This Award does not confer upon the Award Recipient any right to be continued in the employment of, or otherwise provide Services to, the Company or any Subsidiary or other affiliate thereof, or interfere with or limit in any way the right of the Company or any Subsidiary or other affiliate thereof to terminate such Award Recipient’s employment or other service relationship at any time. For
Exhibit 10.12
purposes of this Agreement only, the term “employment” shall include circumstances under which Award Recipient provides consulting or other Services to the Company or any of its Subsidiaries as an independent contractor, but such Award Recipient is not, nor shall be considered, an employee; provided, however, nothing in this Section 6 or this Agreement shall create an employment relationship between such person and the Company or its applicable Subsidiary, as the usages described in this Section are for convenience only.
7.Adjustment of and Changes in Shares of Stock. In the event of any merger, consolidation, recapitalization, reclassification, stock dividend, extraordinary dividend, or other event or change in corporate structure affecting the shares of Stock, the Committee shall make such adjustments, if any, as it deems appropriate in the number and class of shares subject to the Stock Units. The foregoing adjustments shall be determined by the Committee in its sole discretion.
8.Discretionary Nature of Plan. The Plan is discretionary in nature, and the Company may suspend, modify, amend or terminate the Plan in its sole discretion at any time, subject to the terms of the Plan and any applicable limitations imposed by law. This Stock Unit grant under the Plan is a one-time benefit and does not create any contractual or other right to receive additional Stock Units or other benefits in lieu of Stock Units in the future. Future grants, if any, will be at the sole discretion of the Committee, including, but not limited to, the timing of any grant, the number of Stock Units granted, and the vesting provisions.
9.Section 409A. The grant of Stock Units under this Agreement is intended to comply with Code Section 409A to the extent subject thereto, and, accordingly, to the maximum extent permitted, this Agreement will be interpreted and administered to be in compliance with Code Section 409A. Notwithstanding anything to the contrary in the Plan or this Agreement, neither the Company, its Affiliates, the Board, nor the Committee will have any obligation to take any action to prevent the assessment of any excise tax or penalty on Award Recipient under Code Section 409A, and neither the Company, its Affiliates, the Board, nor the Committee will have any liability to Award Recipient for such tax or penalty. For purposes of this Agreement, a termination of Service occurs only upon an event that would be a Separation from Service within the meaning of Section 409A. If, at the time of Award Recipient’s Separation from Service, (1) Award Recipient is a “specified employee” within the meaning of Code Section 409A, and (2) the Company makes a good faith determination that an amount payable on account of Award Recipient’s Separation from Service constitutes deferred compensation (within the meaning of Code Section 409A), the payment of which is required to be delayed pursuant to the six (6)-month delay rule set forth in Code Section 409A to avoid taxes or penalties under Code Section 409A (the “Delay Period”), then the Company will not pay such amount on the otherwise scheduled payment date but will instead pay it in a lump sum on the first business day after the Delay Period (or upon Award Recipient’s death, if earlier), without interest. Each installment of Stock Units that vest under this Agreement (if there is more than one installment) will be considered one of a series of separate payments for purposes of Code Section 409A.
10.Miscellaneous Provisions.
(a)Applicable Law. The validity, construction, interpretation and effect of this instrument will be governed by and construed in accordance with the laws of the State of Delaware, without giving effect to the conflicts of law provisions thereof.
(b)Notice. Any notice required by the terms of this Agreement shall be delivered or made electronically, over the Internet or otherwise (with request for assurance of recipient in a manner typical with respect to communications of that type), or given in writing. Any notice given in writing shall be deemed effective upon personal delivery or upon deposit with the United States Postal Service, by registered or certified mail, with postage and fees prepaid, and shall be addressed to the Company at its principal executive office and to the Award Recipient at the address that he or she has most recently provided to the Company. Any notice given electronically shall be deemed effective on the date of transmission.
(c)Headings. The headings of sections and subsections are included solely for convenience of reference and shall not affect the meaning of the provisions of this Agreement.
(d)Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed to be an original but all of which together will constitute one and the same instrument.
Exhibit 10.12
(e)Amendments. The Board and the Committee shall have the power to alter or amend the terms of the grant of Stock Units as set forth herein from time to time, in any manner consistent with the provisions of the Plan, and any alteration or amendment of the terms of this grant of Stock Units by the Board or the Committee shall, upon adoption, become and be binding on all persons affected thereby without requirement for consent or other action with respect thereto by any such person. The Committee shall give notice to the Award Recipient of any such alteration or amendment as promptly as practicable after the adoption thereof. The foregoing shall not restrict the ability of the Award Recipient and the Board or the Committee by mutual written consent to alter or amend the terms of this grant of Stock Units in any manner which is consistent with the Plan.
(f)Binding Effect. This Agreement shall be binding upon the heirs, executors, administrators and successors of the Award Recipient and the Company.
(g)Entire Agreement. This Agreement and the Plan constitute the entire agreement between the Award Recipient and the Company regarding the grant of Stock Units and supersede all prior arrangements or understandings (whether oral or written and whether express or implied) with respect thereto. In the event the Award Recipient has a Severance Agreement, any conflicts or ambiguities shall be resolved first by reference to the Severance Agreement, then to Plan, and finally to this Agreement.
11.Definitions. For purposes of this Agreement, the following capitalized words shall have the meanings set forth below.
“Change in Control and Severance Agreement” shall mean the Amended Change in Control and Severance Agreement, dated November 1, 2016, between the Award Recipient and the Company.
“Transition and Retirement Agreement” shall mean the Transition and Retirement Agreement, dated February 25, 2019, between the Award Recipient and the Company.
“Separation from Service” shall have the meaning given such term in Code Section 409A.
(Remainder of page intentionally left blank)
Exhibit 10.12
EXECUTED on the date first written above.
|
|
|
|
|
|
COMPANY: |
|
ORTHOFIX MEDICAL INC. |
|
|
|
|
|
|
|
|
|
By: |
/s/ Bradley R. Mason |
|
|
|
Name: Bradley R. Mason |
|
|
|
|
Title: President and Chief Executive Officer |
|
|
|
|
|
|
|
AWARD RECIPIENT: |
|
|
|
|
|
|
By: |
|
|
|
|
Name: Bradley R. Mason |
|
|
|
|
|
|
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 2/24/20 | 8-K | ||
| For Period end: | 12/31/19 | SD | ||
| 2/25/19 | 10-K, 8-K | |||
| 11/1/16 | ||||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/16/24 Orthofix Medical Inc. S-8 4/16/24 8:699K Donnelley … Solutions/FA 3/15/24 Orthofix Medical Inc. S-8 3/15/24 9:765K Donnelley … Solutions/FA 3/05/24 Orthofix Medical Inc. 10-K 12/31/23 120:20M Donnelley … Solutions/FA 1/12/24 Orthofix Medical Inc. S-8 1/12/24 8:693K Donnelley … Solutions/FA 1/08/24 Orthofix Medical Inc. S-8 1/08/24 8:692K Donnelley … Solutions/FA 3/06/23 Orthofix Medical Inc. 10-K 12/31/22 134:28M Donnelley … Solutions/FA 1/10/23 Orthofix Medical Inc. S-8 1/10/23 8:354K Donnelley … Solutions/FA 1/10/23 Orthofix Medical Inc. S-8 POS 1/10/23 9:591K Donnelley … Solutions/FA 1/04/23 Orthofix Medical Inc. S-8 1/04/23 7:645K Donnelley … Solutions/FA 2/25/22 Orthofix Medical Inc. 10-K 12/31/21 120:22M ActiveDisclosure/FA 2/26/21 Orthofix Medical Inc. 10-K 12/31/20 124:22M ActiveDisclosure/FA 9/14/20 Orthofix Medical Inc. S-8 9/14/20 5:388K ActiveDisclosure/FA |